Disseminated classic Kaposi's sarcoma. Two cases with excellent response to pegylated liposomal doxorubicin
- PMID: 17853313
- DOI: 10.1080/09546630600919993
Disseminated classic Kaposi's sarcoma. Two cases with excellent response to pegylated liposomal doxorubicin
Abstract
Pegylated liposomal doxorubicin (PLD) is usually used in disseminated HIV-related Kaposi's sarcoma (KS). It is the first-line treatment or second-line therapy in patients who do not tolerate or do not respond to polychemotherapy since 1995, when it was approved by the FDA. We report two cases of disseminated classic KS not associated with immunosuppression in which HHV-8 infection was demonstrated. They showed an excellent response to PLD, with good tolerance and an absence of side effects.
Similar articles
-
Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.Clin Infect Dis. 2008 Aug 1;47(3):410-7. doi: 10.1086/589865. Clin Infect Dis. 2008. PMID: 18582203 Clinical Trial.
-
Liposomal pegylated doxorubicin versus low-dose recombinant interferon Alfa-2a in the treatment of advanced classic Kaposi's sarcoma; retrospective analysis of three German centers.Cancer Invest. 2005;23(8):653-9. doi: 10.1080/07357900500358259. Cancer Invest. 2005. PMID: 16377582
-
A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma.Oncologist. 2007 Jan;12(1):114-23. doi: 10.1634/theoncologist.12-1-114. Oncologist. 2007. PMID: 17227906 Clinical Trial.
-
Pegylated liposomal doxorubicin: a review of its use in metastatic breast cancer, ovarian cancer, multiple myeloma and AIDS-related Kaposi's sarcoma.Drugs. 2011 Dec 24;71(18):2531-58. doi: 10.2165/11207510-000000000-00000. Drugs. 2011. PMID: 22141391 Review.
-
Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment.Expert Rev Anticancer Ther. 2002 Apr;2(2):193-200. doi: 10.1586/14737140.2.2.193. Expert Rev Anticancer Ther. 2002. PMID: 12113241 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical